annual CFI:
$125.57M+$156.91M(+500.57%)Summary
- As of today (July 27, 2025), NTLA annual cash flow from investing activities is $125.57 million, with the most recent change of +$156.91 million (+500.57%) on December 31, 2024.
- During the last 3 years, NTLA annual CFI has risen by +$676.35 million (+122.80%).
- NTLA annual CFI is now -21.67% below its all-time high of $160.31 million, reached on December 31, 2022.
Performance
NTLA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$94.33M-$57.24M(-37.76%)Summary
- As of today (July 27, 2025), NTLA quarterly cash flow from investing activities is $94.33 million, with the most recent change of -$57.24 million (-37.76%) on March 31, 2025.
- Over the past year, NTLA quarterly CFI has increased by +$88.43 million (+1498.51%).
- NTLA quarterly CFI is now -37.76% below its all-time high of $151.56 million, reached on December 31, 2024.
Performance
NTLA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$213.99M+$88.43M(+70.42%)Summary
- As of today (July 27, 2025), NTLA TTM cash flow from investing activities is $213.99 million, with the most recent change of +$88.43 million (+70.42%) on March 31, 2025.
- Over the past year, NTLA TTM CFI has increased by +$117.19 million (+121.06%).
- NTLA TTM CFI is now at all-time high.
Performance
NTLA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NTLA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +500.6% | +1498.5% | +121.1% |
| 3 y3 years | +122.8% | +98.7% | +144.8% |
| 5 y5 years | +398.8% | +64.2% | +45.9% |
NTLA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.7% | +122.8% | -37.8% | +177.2% | at high | +151.5% |
| 5 y | 5-year | -21.7% | +122.8% | -37.8% | +123.6% | at high | +135.5% |
| alltime | all time | -21.7% | +122.8% | -37.8% | +123.6% | at high | +135.5% |
NTLA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $94.33M(-37.8%) | $213.99M(+70.4%) |
| Dec 2024 | $125.57M(-500.6%) | $151.56M(-2066.1%) | $125.57M(+529.7%) |
| Sep 2024 | - | -$7.71M(-68.1%) | $19.94M(-81.4%) |
| Jun 2024 | - | -$24.19M(-509.9%) | $107.15M(+10.7%) |
| Mar 2024 | - | $5.90M(-87.2%) | $96.80M(-408.8%) |
| Dec 2023 | -$31.35M(-119.6%) | $45.94M(-42.2%) | -$31.35M(-70.8%) |
| Sep 2023 | - | $79.50M(-330.2%) | -$107.44M(-22.9%) |
| Jun 2023 | - | -$34.54M(-71.7%) | -$139.29M(+1380.0%) |
| Mar 2023 | - | -$122.25M(+305.4%) | -$9.41M(-105.9%) |
| Dec 2022 | $160.31M(-129.1%) | -$30.15M(-163.3%) | $160.31M(+411.4%) |
| Sep 2022 | - | $47.64M(-50.0%) | $31.35M(-107.5%) |
| Jun 2022 | - | $95.34M(+100.8%) | -$415.68M(-13.0%) |
| Mar 2022 | - | $47.47M(-129.8%) | -$477.76M(-13.3%) |
| Dec 2021 | -$550.78M(+156.8%) | -$159.12M(-60.2%) | -$550.78M(-8.6%) |
| Sep 2021 | - | -$399.38M(-1300.8%) | -$602.58M(+68.7%) |
| Jun 2021 | - | $33.26M(-230.2%) | -$357.18M(+20.1%) |
| Mar 2021 | - | -$25.54M(-87.9%) | -$297.48M(+38.7%) |
| Dec 2020 | -$214.49M | -$210.92M(+37.0%) | -$214.49M(-982.1%) |
| Sep 2020 | - | -$153.98M(-265.6%) | $24.32M(-83.4%) |
| Jun 2020 | - | $92.96M(+61.8%) | $146.64M(+90.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $57.45M(+106.0%) | $76.93M(+205.6%) |
| Dec 2019 | $25.18M(-109.7%) | $27.88M(-188.1%) | $25.18M(-109.7%) |
| Sep 2019 | - | -$31.65M(-236.1%) | -$258.72M(+12.9%) |
| Jun 2019 | - | $23.25M(+308.2%) | -$229.09M(-9.5%) |
| Mar 2019 | - | $5.70M(-102.2%) | -$253.24M(-2.9%) |
| Dec 2018 | -$260.78M(+2484.3%) | -$256.02M(>+9900.0%) | -$260.78M(+3540.7%) |
| Sep 2018 | - | -$2.02M(+124.0%) | -$7.16M(-3.3%) |
| Jun 2018 | - | -$900.00K(-51.4%) | -$7.41M(-4.8%) |
| Mar 2018 | - | -$1.85M(-22.8%) | -$7.78M(-22.9%) |
| Dec 2017 | -$10.09M(+63.7%) | -$2.40M(+6.1%) | -$10.09M(-9.1%) |
| Sep 2017 | - | -$2.26M(+77.7%) | -$11.10M(+17.5%) |
| Jun 2017 | - | -$1.27M(-69.4%) | -$9.44M(+1.3%) |
| Mar 2017 | - | -$4.16M(+22.2%) | -$9.32M(+51.2%) |
| Dec 2016 | -$6.17M(+141.4%) | -$3.40M(+462.8%) | -$6.17M(+70.8%) |
| Sep 2016 | - | -$605.00K(-47.3%) | -$3.61M(+0.1%) |
| Jun 2016 | - | -$1.15M(+13.8%) | -$3.61M(+18.4%) |
| Mar 2016 | - | -$1.01M(+18.7%) | -$3.05M(+19.3%) |
| Dec 2015 | -$2.55M | -$849.00K(+41.0%) | -$2.55M(+49.8%) |
| Sep 2015 | - | -$602.00K(+2.6%) | -$1.71M(+54.6%) |
| Jun 2015 | - | -$587.00K(+13.8%) | -$1.10M(+113.8%) |
| Mar 2015 | - | -$516.00K | -$516.00K |
FAQ
- What is Intellia Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual CFI year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Intellia Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM CFI year-on-year change?
What is Intellia Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of NTLA is $125.57M
What is the all time high annual CFI for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual cash flow from investing activities is $160.31M
What is Intellia Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, NTLA annual cash flow from investing activities has changed by +$156.91M (+500.57%)
What is Intellia Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of NTLA is $94.33M
What is the all time high quarterly CFI for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $151.56M
What is Intellia Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, NTLA quarterly cash flow from investing activities has changed by +$88.43M (+1498.51%)
What is Intellia Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of NTLA is $213.99M
What is the all time high TTM CFI for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM cash flow from investing activities is $213.99M
What is Intellia Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, NTLA TTM cash flow from investing activities has changed by +$117.19M (+121.06%)